MAPK1 antibody review

ExactAntigen

MAPK1 antibody review

MAPK1 antibodies
This is a review about MAPK1 antibodies, based on 178 published articles using MAPK1 antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited MAPK1 antibody. Information in this review (with links to publications) can be searched freely .

EMSA (emsa), immunocytochemistry (ic), immunohistochemistry (ih), immunoprecipitation (ip), western blot (wb)

CELL SIGNALING TECHNOLOGY search Cell Signaling Technology MAPK1 products includes other brands or spellings
emsa		Cell Signaling anti-phospho-Erk1/2 (Thr-202/Tyr-204) antibody was used to investigate the activation of Erk1/2 by intracellular M. leprae.
ic, wb		Cell Signaling Technology monoclonal mouse anti-phospho-ERK antibody and polyclonal goat anti-ERK2 antibody were used in human HEK-293 cells and in western blot, immunocytometry to study the molecular mechanism by which D2R and D3R activates ERK1/2.
ic, wb		Cell Signaling pERK1/2 polyclonal antibody was used to investigate the role of GIT1 in ERK1/2 activation during focal adhesions.
ic		Cell Signaling Technology anti-phospho-ERK1/2 antibody was used in western blot to detect activated ERK in mouse NIH3T3 cells and human A431, HT1080 and HeLa cell lines, and in immunocytochemistry to detect the localization of phosphorylated ERK1/2 in mouse NIH3T3 cells and human A431 cells.
ih, wb		Cell Signaling Technology anti-phospho-ERK1/2 antibody and anti-ERK1/2 antibody were used in western blot to study the relationship between FPR expression and the biologic behavior of glioma cells.
ih		Cell Signaling anti-phospho-p44/42 MAPK (Thr-202/Tyr-204) antibody was used in immunohistochemistry to study the role of AGF in epidermal keratinocytes.
ih		Cell Signaling Technology monoclonal anti-p-ERK1/2 (Thr202/Tyr204) antibody was used in paraffin sections from human tumors and immunohistochemistry to study the role of activated Akt expression in prognosis of pancreatic ductal adenocarcinoma.
ih		Cell Signaling Technology Inc rabbit polyclonal antibody against human p-ERK (MAPK detection kit, 9910) was used in immunohistochemistry to study the inhibition effect of sphingosine-1-phosphate on nuclear factor kappa B activation and germ cell apoptosis in the human testis independently of its receptors.
ih		Cell Signaling Technology rabbit polyclonal anti-phospho-p44/42 MAP kinase (Thr 202/Tyr 204) antibody was used in immunohistochemistry to study the expression of phospho-specific Akt in human prostate cancer.
ip, wb		Cell Signaling Technology anti-p42/44 MAPK and anti-phospho-p42/44 MAPK antibodies were used in western blot and immunoprecipitation to study the role of p42/44 MAPK and protein kinase B in CTGF induced extracellular matrix protein production, cell migration, and actin cytoskeletal rearrangement in human mesangial cells.
ip, wb		New England Biolabs anti-MAPK and phospho-MAPK polyclonal antibody was used in western blot and immunoprecipitation to detect MAPK and phospho-MAPK in NCI-H1299 cells.
ip, wb		Cell Signaling extracellular signal-regulated kinase (ERK) 1/2 and phospho-ERK1/2 antibodies ((9, 102/9, 121) were used in western blot and immunoprecipitation to investigate the regulatoin of Fbw7-mediated cyclin E proteolysis by Ras.
ip		Cell Signaling phospho-MAPK mAb was used in western blot to study HER-2 down-regulation in colon cancer cells.
wb		Cell Signaling Technology monoclonal anti-phospho-ERK antibody was used in western blot to study the role of Rit in human neuroblastoma cells for MEK-independent neurite branching.
wb		Cell Signaling Technology anti-total ERK and anti-phospho-ERK antibodies were used in western blot to study the function of RNase L and c-Jun NH2-terminal kinase in the interferon antiviral response.
wb		Cell Signaling Technology ERK1/2 and phospho-ERK1/2 antibodies were used in western blot to study regulation of monocyte matrix metalloproteinase-1 and -9 by interferon-gamma.
wb		Cell Signaling Technology diphospho-Erks (anti-Thr-202/Tyr-204 phosphorylated p44/p42) mouse monoclonal antibodies was used in western blot to study the Multifunctional Protein CAD which is phosphorylized by nuclear localization and mitogen-activated protein kinase.
wb		Cell Signaling Technology anti-pMAPK antibody was used in western blot to identify two substrates in insulin signaling, IRS5/DOK4 and IRS6/DOK5.
wb		Cell Signaling Technology anti-phospho- (9101s) p42 MAPK antibody was used in western blot to study the role of Ciliary neurotrophic factor (CNTF) to induce the dedifferenciation of adult human myoblasts via p44/p42 MAPK pathway in vitro.
wb		New England Biolabs anti-phospho-ERK1/2 antibody was used in western blot to study the biological characteristics of insulin/insulin-like growth factor I hybrid receptors.
wb		Cell Signaling antibody against phosphorylated Erk2 was used in western blot to identify a putative G protein-coupled receptors (GPCR) as an intermediary in meiotic maturation of fish oocytes.
wb		Cell Signaling Technology anti-ERK2 antibody was used in western blot to study the inhibitory effects of galanin receptor 1 on proliferation in oral squamous cell carcinoma.
wb		Cell Signaling E10 monoclonal phospho-ERK1/2 antibody was used in western blot to study a novel link between GILZ and regulation of epithelial sodium transport through modulation of ERK signaling.
wb		Cell Signaling Technology anti-phospho-ERK antibody was used in western blot to study the cellular and molecular function of a novel interferon- and LPS-inducible gene designated FLN29 that acts as a negative regulator in TLR signaling.
wb		Cell Signaling Technology anti-phospho-ERK 1/2 and anti-ERK 1/2 antibodies were used in western blot to study the regulation and the functional consequences after the extracellular N terminus of the endothelin B (ETB) receptor is cleaved by a metalloprotease.
wb		New England Biolabs antibody against phospho-Erk1 and 2 was used in western blot to study the significance of the dimerization function associated with the BTB/POZ domain of Keap1 for sequestration of Nrf2 in the cytoplasm.
wb		New England Biolabs antiphospho-ERK1/2 (P-ERK1/2) antibody was used in western blot to study the function of Gs-coupled receptors to induce activation of H-Ras and the ERK1/2 MAP kinases by an Epac- and Ca2+-controlled pathway.
wb		CST anti-ERK polyclonal antibody was used in western blot to study the CDX1 as an important molecular mediator of Barrett's metaplasia.
wb		New England BioLabs anti-phospho-ERK polyclonal antibody was used in western blot to investigate a novel mechanism for the regulation of Rac activity and lamellipodia formation by RET tyrosine kinase.
wb		New England Biolabs anti-phosphoErk1/2 polyclonal antibody was used in western blot to further elucidate the activation mechanism for intracellular signaling mediated by interaction between Dok1 and phosphorylated RET.
wb		Cell Signaling Technologies anti-phosphorylated ERK polyclonal antibody was used in western blot to study the mitogenic activity of urokinase-type plasminogen activator which is determined by the dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex.
wb		Cell Signaling Technology anti-phospho-p44/42 MAPK (Thr202/Tyr204) antibody was used in western blot to study the regulation of activity of the human tissue factor pathway inhibitor-2 promoter by the ERK/MAPK pathway.
wb		New England Biolabs rabbit anti-ERK2 polyclonal antibody was used in western blot to study the frequent co-Localization of cox-2 and laminin-5 2 chain at the invasive front of early-stage lung adenocarcinomas.
wb		Cell Signaling anti-ERK polyclonal antibody was used in western blot to study the overexpression of mitogen-activated protein kinase phosphatase-1 which is an independent predictor of outcome in patients in non-small cell lung cancer.
wb		New England Biolabs antibody to p42/44 MAP kinase was used in western blot to study the role of CD147 as a cell surface receptor for CyPA and an essential component in the CyPA-initiated signaling cascade that culminates in ERK activation.
wb		New England Biolabs anti-total-ERK antibodies and anti-phospho-ERK antibodies were used in western blot to study the function of beta-arrestin2 as a mediator of stromal cell-derived factor 1alpha-induced chemotaxis via the ASK1/p38 MAPK pathway.
wb		New England Biolabs mouse anti-phospho-p44/42 mitogen-activated protein kinase (Thr-202/Tyr-204) E10 mAb was used in western blot to study the Initiation of CD38 signaling in T Cells within a subset of membrane rafts containing Lck and the CD3-zeta subunit of the T cell antigen receptor.
wb		Cell Signaling anti--phospho-ERK2 antibody was used in western blot to study the effect of signal transducers and activators of transcription 3 on the transcriptional activity of CCAAT/enhancer-binding protein β in granulocyte colony-stimulating factor signaling pathway.
wb		Cell Signaling Technology anti-phospho-Erk antibody was used in western blot to study the effect of receptor-type protein-tyrosine phosphatase-κ on epidermal growth factor receptor function.
wb		Cell Signaling anti-phospho-ERK antibody was used in western blot to study the regulation of heterodimerization β1/β2-adrenergic receptor for β2-adrenergic receptor internalization and ERK signaling efficacy.
wb		Cell Signaling Technology anti-phospho p42 mitogen-activated protein kinase (ERK2) antibody was used in western blot to study the interaction of Bcr kinase and AF-6 and the effects of them on Ras signaling.
wb		Cell Signaling Technology anti-phospho MAPK p38 and anti-MAPK p38 antibodies were used in western blot to study cells with mutant IGF-I receptor at tyrosines 1250 and 1251.
wb		Cell Signaling Technology anti-p42/44 extracellular signal-regulated kinase (ERK) (Thr 202/Tyr 204) and anti-ERK antibodies were used in western blot to study the role of adiponectin in angiogenesis.
wb		Cell Signaling Technology rabbit antibody against the phosphorylated forms of ERK1/2 (Thr202/Tyr204 phospho-p44/42 MAPK) was used in western blot to study the role for PI 3-kinase in HHV-8 entry into the target cells and the role for PKC-zeta, MEK, and ERK at a post-viral entry stage of infection.
wb		Cell Signaling Technology anti-ERK and phospho-ERK antibody was used in western blot to study the expression of hypertonicity-induced aquaporin-1 (AQP1) which is mediated by the activation of MAPK pathways and hypertonicity-responsive element in the AQP1 gene.
wb		Cell Signaling Technology anti-Erk 2 and phospho-Erk 2 antibody was used in western blot to study that resveratrol increases serine15-phosphorylated but transcriptionally impaired p53 and induces a reversible DNA replication block in serum-activated vascular smooth muscle cells.
wb		Cell Signaling Technology anti-ERK2 and phospho-ERK2 rabbit polyclonal antibody was used in western blot to detect ERK2 and phospho-ERK2 in baculovirus infected with different versions of human Itk.
wb		Cell Signaling Technology rabbit polyclonal anti-P42 MAPK and phospho-P42 MAPK antibody was used in western blot to detect P42 MAPK and phospho-P42 MAPK in fibroblasts containing wild type Cas, CasY253F, or Cas118423.
wb		Cell Signaling Technology antibody against phosphorylated ERK was used in western blot to examined the Ser/Thr phosphorylation status of ERK in control HUVECs and HeLa cells.
wb		Cell Signaling Technology anti-p42 MAPK and phopho-p42 MAPK antibody was used in western blot to detect p42 MAPK and phopho-p42 MAPK in SK-LMS-1 cells and MDA-MB-231 cells with human TSP1 transfection.
wb		Cell Signaling Technology anti phospho-ERK2 antibody was used in western blot to detect phospho-ERK2 in 3T3-L1 cells infected with a retrovirus carrying the gene for C/EBPalpha.
wb		Cell Signaling anti-phospho-p42 MAPK antibody was used in western blot to detect phospho-p42 MAPK in rat cardiac myocytes infected with recombinant adenoviruses containing human wild type or mutant cDNA of RasGAP, Akt or ILK.
wb		Cell Signaling Technology rabbit polyclonal anti-phospho-p42 ERK antibody was used in western blot to detect phospho-p42 ERK in NR6 WT cells and NR6 c'973 cells.
wb		Cell Signaling Technology anti-p42 MAPK and phospho-p42 MAPK antibody was used in western blot to detect Akt and phospho-Akt in ET-1-treated lung fibroblasts from open lung biopsy specimens from SSc patients.
wb		Cell Signalling Technology rabbit polyclonal phospho-ERK antibody was used in Western blot to study the role of PPARgamma and EGFR signalling.
wb		Cell Signaling anti-phospho-ERK2 antibody was used in western blot to detect phospho-ERK2 in human differentiated myotubes stimulated with insulin.
wb		Cell Signaling anti-Erk2 and phospho-Erk2 antibody was used in western blot to detect Erk2 and phospho-Erk2 in human coronary artery endothelial cells (HCAEC) treated with VEGF or HGF.
wb		Cell Signaling anti-phospho-p42 MAPK antibody was used in western blot to detect phospho-p42 MAPK in HT-29 cells treated with NMT1-1 siRNA or NMT2-4 siRNA.
wb		Cell Signaling anti-p42 MAP kinase antibody was used in human embryonic kidney 293T with α7 and hric3 DNAs and in western blot to study the effects of hric3 on α7 receptors.
wb		New England Biolabs mouse anti-phospho-ERK2 antibody was used in western blot to detect phospho-ERK2 in PAK4 knockdown (RNAi) cells untreated or treated with TNFalpha+CHX.
wb		Cell Signaling Technologies anti-ERK2 and phospho-ERK2 antibody was used in western blot to detect ERK2 and phospho-ERK2 in HEK cells subject to knockdown of either PDE4D or PDE4B.
wb		Cell Signaling Technology antibody that recognizes phospho-ERK was used in western blot to investigate the activation of ERK1/2 in primary human melanocytes isolated from neonatal foreskins and in the human melanoma SK-MEL-24 and SK-MEL-28 cell lines.
wb		Cell Signaling anti-ERK2 and phospho-ERK2 antibody was used in western blot to detect ERK2 and phospho-ERK2 in human ejaculate spermatozoa.
wb		New England Biolabs anti-ERK and anti-phospho-ERK antibodies were used in western blot to investigate ERK activity in A549 human lung cancer cells.
wb		Cell Signaling anti-ERK2 and phospho-ERK2 antibody was used in western blot to detect ERK2 and phospho-ERK2 in mutant and normal lymphocytes from patients.
wb		Cell Signaling Technology anti-phospho-p42MAPK antibody was used in western blot to detect phospho-p42MAPK in NIH 3T3 cells transiently transfected with vector, RACK1, or mutant RACK1 and HEK 293 cells transfected with RACK1 siRNAs.
wb		Cell Signaling Technology polyclonal anti-phospho-p38 and anti-pan-p38 antibodies were used in human umbilical vein endothelial cells (HUVECs) and in western blot to study the effect of enhanced p38 MAPK activity on endothelial cell function.
wb		New England Biolabs anti-ERK/MAPK (p44/p42) and anti-phospho-ERK/MAPK antibodies were used in human UT7D1, 11OC1, HEL, K562, and HMC1 cells and in western blot to study the effect of ERK and p38 on 4E-BP1 expression.
wb		Cell Signaling Technology monoclonal anti-p42/44 MAP kinase antibody was used in human MCF-7 cells (which were ransfected with plasmids encoding HA-RACK1) and in western blot to study the role for the interaction between RACK1 and insulin-like growth factor 1 (IGF-1) receptor in regulating IGF-1-mediated Akt activation and protection from cell death.
wb		Cell Signalling Technology anti-phospho-Erk2 antibody was used in western blot to detect phospho-Erk2 in HeLa cells with FTI treatment.
wb		Cell Signaling phospho-p42/44 was used in western blot to investigate the phosphorylation of ERK1/2 in human microvascular endothelial cells isolated by enzymatic digestion of blood vessels taken from the mesentery of the small bowel (designated MM1 cells).
wb		New England BioLabs monoclonal anti-phospho-ERK2 antibody was used in western blot to detect phospho-ERK2 in A549 cells.
wb		New England BioLabs anti-phospho-ERK2 antibody was used in western blot to detect phospho-ERK2 in D5 and vector HEK293 cells untreated or treated with insulin.
wb		Cell Signaling anti-phosphorylated ERK antibody was used in western blot to detect phosphorylated ERK in A549 cells infected with RSV.
wb		Cell Signaling Technology rabbit polyclonal anti-phospho-p42 MAP kinase antibody was used in western blot to detect Erk-2 in HUVEC.
wb		New England Biolabs anti-phosphorylated p42 MAPK antibody was used in western blot to detect phosphorylated p42 MAPK in chlorate-treated Rama 27 fibroblasts.
wb		Cell Signaling anti-ERK and phosphorylated ERK antibody was used in western blot to detect ERK and phosphorylated ERK in RAW264.7 and CL-2 cells activated with IFN-gamma or LPS.
wb		Cell Signaling anti-phospho-p44/42 mitogen-activated protein kinase (Thr-202/Tyr-204) antibody (catalog number 9106) was used in human LNCaP cells and in western blot to study the role of epidermal growth factor in transforming growth factor beta signaling and growth suppression.
wb		New England Biolabs anti-phospho-p44/42 MAPK (p-ERK1/2) antibody was used in human A549 cells and in western blot to study the interaction between the receptor protein-tyrosine phosphatase PTPµ and IQGAP1.
wb		Cell Signaling rabbit polyclonal anti-phospho-MAPK (p42/p44) antibody was used in human 293T cells and in western blot to study the effect of RET/PTC3 on the Erk8 mitogen-activated protein (MAP) kinase.
wb		New England Biolabs anti-phospho-ERK antibody was used in mouse B104-1-1 cells and in western blot to study the role for the effect of HER-2/neu on RECK expression in promoting cell invasion.
wb		Cell Signaling Technology anti-Erk2 and anti-phospho-Erk2 were used in western blot to detect Erk2 and phosphorylated Erk2 in human HeLa cells.
wb		Cell Signaling Technologies anti-phospho-p42/44 MAPK was used in western blot to detect the phosphorylation of p42/44 MAPK in primary neonatal human melanocytes.
wb		Cell Signaling Technology anti-p44/42 MAPK and anti-phospho-p44/42 MAPK (Thr202/Tyr204) were used in western blot to detect ERK and activation of ERK, respectively, in human renal carcinoma ACHN cells.
wb		Cell Signaling Technology ERK and phospho-ERK (Thr202/Tyr204) antibodies were used in western blot to detect ERK and phosphorylated ERK respectively in human HEK 293 cells.
wb		Cell Signaling antibody directed against phosphorylated p44/p42 MAPK was used in western blot to detect the presence of phosphorylated MAPK in porcine aortic endothelial (PAE) cells.
wb		Cell Signaling anti-phospho-ERK1/2 was used in western blot to examine the levels of activated ERK in A2780 and OVCAR5 ovarian cancer cell lines and human HEK293 cells.
wb		Cell Signaling Technology antibodies for MAPK (ERK1/2) and phospho-p44/42 MAPK (P-ERK1/2) were used in Western blot to study the biological function of estrogen receptors in the rapid effects of resveratrol and estradiol.
wb		Cell Signaling Technology anti-phosphorylated extracellular signal-regulated kinase (ERK) 1/2 (Thr202/Tyr204) antibody was used in human HEK293T cells and in western blot to study the antagonizing of the receptor-type protein tyrosine phosphatase J for effects of RET-derived oncoproteins.
wb		New England Biolabs anti-phospho MAPK 1, 2 and nonphosphorylated MAPK 1, 2 antibodies were used in human breast cancer cells and in western blot to study the role for Q227L-Gα in inhibiting growth of established tumors of later-stage human breast cancer cells in athymic mice.
wb		Cell Signaling Technology antibody against phospho-ERK2 was used in western blot to study the regulation of inducible cyclooxygenase-2 and prostaglandin E2 synthesis by Clostridium difficile toxin A via reactive oxygen species and activation of p38 MAPK.
wb		Cell Signaling Technology anti-ERK-1/2 and anti-phosphorylated ERK-1/2 antibodies were used in Western blot to study the biological function of Rac-MKK3/6-p38 pathway.
wb		Cell Signaling Technology polyclonal anti-phospho-ERK1/2 antibody was used in western blot to study the GIPC interaction with beta1-adrenergic receptor and its regulation on beta1-adrenergic receptor-mediated ERK activation.
wb		New England Biolabs monoclonal antiactive phospho-p42/p44 antibody was used in western blot to study the proangiogenic activity of AFP in the fetomaternal unit and its possible role during pregnancy in the present study.
wb		New England BioLabs Use PhosphoPlus p42/44 MAPK (Thr202/Tyr204) Antibody Kit was used to study ras activation by acute hyperglycemia.
wb		New England Biolabs rabbit anti-human p42 MAPK (1:1000) was used in western blot to study the changes of retinal gene expression in proliferative vitreoretinopathy.
wb		Cell Signaling Technologies polyclonal anti-phospho-p44/42 (ERK1/2, Thr-202/Tyr-204) antibody was used in western blot to study glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression.
wb		Cell Signaling Technology rabbit phosphorylated p38 MAPK antibody was used in western blot to study tumor necrosis factor-alpha signaling pathways.
wb		Cell Signaling Technology phospho-Erk1/2 (T202/Y204) and Erk1/2 antibodies were used in western blot to study interleukin 7 effects on T cell acute lymphoblastic leukemia cells.
wb		New England BioLabs ERK and phospho-ERK antibodies were used in western blot to study IL-1 -mediated MUC2 gene expression and mucin secretion in NCI-H292 cells via zctivation of PKC-MEK/ERK, and PI3K in human airway epithelial cells.
wb		Cell Signaling Technology ERK1 and -2 (Thr202/Tyr204) antibody was used in western blot to study VEGF mRNA stability in DU145 prostate carcinoma.
wb		New England Biolabs rabbit polyclonal p38 MAPK (Thr180/Tyr182) antibody was used in western blot to study stress-induced ATF6 phosphorylation.
wb		New England BioLabs anti-phospho p38 antibody was used in western blot to study the interaction between TAB1 isoform and p38alpha.
wb		New England BioLabs phospho-specific ERK2 antibody was used in western blot to study the ERK5 signaling pathway regulation by PTP-SL.
wb		Cell Signaling phospho-44/42 MAPK (Thr202-Tyr204) antibody was used in western blot to characterize heparin affin regulatory peptide signaling in human endothelial cells.
wb		Cell Signaling Technology rabbit anti-ERK1/2 and anti-phospho-ERK1/2 (Thr-202/Tyr-204) antibodies was used in western blot to study the role of RSK in signaling chemokine responses and synthesis in astrocytes.
wb		New England Biolabs anti-MAP kinase antibody that recognizes both p44 and p42 MAP kinases was used in western blot to study the role of Ng in neural function using a strain of Ng knockout mouse.
wb		Cell Signaling Technology rabbit polyclonal anti-phospho-p44/42 MAP kinase (Thr202/Tyr204), and anti-p44/42 MAP kinase antibodies were used in western blot to study expression of p53, ErbB1, ErbB2, and Raf-1 in lung cancer.
wb		Cell Signaling Technology phosphospecific rabbit ERK-1/2 antibody was used in western blot to study a potential role for tyrosine phosphatases.
wb		Cell Signaling Technology anti-phospho-p44/42 mitogen-activated protein kinase (Thr202 and Tyr204) antibody was used in western blot to study cell survival by GLP-2R signaling.
wb		Cell Signaling Technology rabbit polyclonal ERK 1/2 and phospho-ERK 1/2 (thr202/tyr204) antibodies were used in western blot to study the interactions between pharmacological MEK1/2 inhibitors and STI571 in Bcr/Abl-positive human leukemia cells.
wb		New England Biolabs anti-ERK1/2 antibody was used in western blot to study the role of CRHR2 in the control fo myometrial contractility.
wb		New England Biolabs rabbit monoclonal anti-phospho-p42/44 MAPK antibody was used in western blot to study the protective role of SCP and SRP against hypoxia/rexygenation injury in rat neonatal cardiomyocytes.
wb		Cell Signaling Technology anti- phospho-p38MAPK antibody was used in western blot to study the regulation of the phosphorylation of MAP kinases by UVB.
wb		Cell Singaling Technology anti-phospho-p42 ERK antibody was used in western blot to study the function of the mitogen-activated protein kinase kinase kinase DLK as a key regulator of keratinocyte terminal differentiation.
wb		Cell Signaling Inc rabbit anti-total-ERK antibody was used in western blot to study the HSulf-1 and HSulf-2.
wb		Cell Signaling PhosphoPlus MAPK antibody kit was used in western blot to study the inhibition of activator protein-1, NF-{kappa}B, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid.
wb		Cell Signaling anti-phospho-p44/42 Map kinase (Thr-202/Tyr-204) rabbit polyclonal and anti-p44/42 Map kinase rabbit polyclonal antibodies were used in western blot to study the association of PDGFRB and LRP.
wb		Cell Signaling Technology anti-Erk2antibodies was used in Western blotting to study the central role for the Hsp90.Cdc37 molecular chaperone module in interleukin-1 receptors.
wb		Cell Signaling Technologies anti-ERK and anti-phospho-ERK antibodies were used in western blot to study selective modulation of Gbetagamma subunit functions by small molecules.
wb		Cell Signaling Technology rabbit polyclonal ERK and phospho-ERK antibodies were used in western blot to study the effect on BAD phosphorylation and Bcl-2 association by Raf-1 phosphorylation.
wb		New England Biolabs phosphospecific ERK1/2 antibody was used in western blot to study the inhibition of matrix metalloproteinase-9 expression by ascochlorin.
SIGMA-ALDRICH search Sigma-Aldrich MAPK1 products includes other brands or spellings
ic, wb		Sigma monoclonal mouse anti-phospho-ERK antibody and polyclonal goat anti-ERK2 antibody were used in human HEK-293 cells and in western blot, immunocytometry to study the molecular mechanism by which D2R and D3R activates ERK1/2.
ic, wb		Sigma pERK1/2 monoclonal antibody was used in western blot and immunocytochemistry to investigate the role of GIT1 in ERK1/2 activation during focal adhesions.
wb		Sigma anti-ERK-2 antibody was used in western blot to study the inducing of platelet-derived growth factor C to liver fibrosis, steatosis, and hepatocellular carcinoma.
wb		Sigma anti-active/phosphorylated form of ERK-1 and 2 monoclonal antibody was used in western blot to identify DUSP6 as one of the key players in the tumor suppressive pathway and as a promising molecular target for curing patients with pancreatic cancer.
wb		Sigma mouse monoclonal phosphorylated ERK1/2 (p-ERK1/2) antibody was used in Western blot to study the biological function of 15 (S) -hydroxyeicosatetraenoic acid in PKCaplpha translocation.
wb		Sigma anti-ERK2 and activated-ERK2 antibody was used in western blot to detect ERK2 and activated-ERK2 in total cell extracts from HCV core-positive HepG2 cells transfected or not with siRNA core.
wb		Sigma rabbit anti-ERK1/2 (M-5670) and mouse monoclonal anti-phospho-ERK1/2 (M-8159) antibodies were used in western blot to study the MMP-1 expression downregulation by Cdc42 inhibiting the ERK1/2 pathway.
wb		Sigma-Aldrich mouse anti-MAPK and rabbit antiphosphorylated MAPK antibodies were used in western blot to study L1 expression in colon cancers.
wb		Sigma monoclonal anti-phosphoErk antibody was used in western blot to study the role of phosphoinositide 3-kinase beta lipid products in LPA-induced Ras activation.
wb		Sigma-Aldrich Fine Chemicals anti-ERK or anti-phospho ERK antibodies were used in western blot to study the effect of ERK-mediated phosphorylation on the interactions of beta and gamma ENaC with Nedd4.
wb		Sigma polyclonal MAPK and monoclonal phospho-specific MAPK antibodies were used in western blot to study galectin-8 signalling pathway.
SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology MAPK1 products includes other brands or spellings
ic, ip, wb		Santa Cruz Biotechnology rabbit polyclonal antibody against ERK2 was used in western blot, immunoprecipitation and immunocytochemistry to investigate the phosphatidylinositol 3-kinase-PKC-zeta-MEK-ERK signaling pathway mediated by Kaposi's sarcoma-associated herpesvirus early during infection of target cells.
ic, wb		Santa Cruz Biotechnology monoclonal mouse anti-phospho-ERK antibody and polyclonal goat anti-ERK2 antibody were used in human HEK-293 cells and in western blot, immunocytometry to study the molecular mechanism by which D2R and D3R activates ERK1/2.
ic		Santa Cruz Biotechnology anti-ERK2 antibody was used in immunocytochemistry to study the role of NNK for lung cancer cell migration and invasion in a mechanism involving phosphorylation of calpains.
ih		Santa Cruz rabbit polyclonal antibody against human ERK was used in immunohistochemistry to study the inhibition effect of sphingosine-1-phosphate on nuclear factor kappa B activation and germ cell apoptosis in the human testis independently of its receptors.
ip, wb		Santa Cruz Biotechnology anti-Erk-2 antibody was used in western blot and immunoprecipitation to study that extracellular matrix enhances heregulin-dependent BRCA1 phosphorylation and suppresses BRCA1 expression through its C terminus.
ip, wb		Santa Cruz Biotechnology ERK2 (K23) antibody was used in western blot and immunoprecipitation to study the ERK5 signaling pathway regulation by PTP-SL.
ip, wb		SCBT ERK1/2 polyclonal antibody was used in western blot and immunoprecipitation to investigate the role of GIT1 in ERK1/2 activation during focal adhesions.
ip		Santa Cruz Biotechnology anti-Erk2 antibody was used in immunoprecipitation to study the effect of a dominant negative form of Erk2 on TACE phosphorylation at T735.
wb		Santa Cruz Biotechnology anti-phospho-ERK (catalog no. 7383) antibody was used in western blot to study tumor necrosis factor alpha-dependent drug resistance to purine and pyrimidine analogues in human colon tumor cells.
wb		Santa Cruz Biotechnology anti-phosphorylated ERK antibody (which detects phosphorylated ERK1 and ERK2) was used in western blot to study the effects of TL1A-induced NF- B and c-IAP2 on DR3-mediated apoptosis in TF-1 cells.
wb		Santa Cruz Biotechnology anti-ERK2 antibody C14 was used in western blot to study the direct interaction between human CNK1 and Raf-1.
wb		Santa Cruz Biotechnology rabbit anti-ERK2 antibody C-14 was used in western blot to study a novel BASH N terminus-associated protein (BNAS2).
wb		Santa Cruz Biotechnology goat polyclonal antibody against total-ERK 1/2 was used in western blot to study a novel link between GILZ and regulation of epithelial sodium transport through modulation of ERK signaling.
wb		Santa Cruz Biotechnology anti-ERK (C-14) was used in western blot to study the cellular and molecular function of a novel interferon- and LPS-inducible gene designated FLN29 that acts as a negative regulator in TLR signaling.
wb		Santa Cruz Biotechnology anti-ERK antibody was used in western blot to study the function of Gs-coupled receptors to induce activation of H-Ras and the ERK1/2 MAP kinases by an Epac- and Ca2+-controlled pathway.
wb		Santa Cruz Biotechnology anti-Erk1/2 polyclonal antibody was used in western blot to further elucidate the activation mechanism for intracellular signaling mediated by interaction between Dok1 and phosphorylated RET.
wb		Santa Cruz Biotechnology rabbit anti-ERK and mouse anti-phospho-ERK antibodies were used in western blot to study the effect of activation of vascular endothelial growth factor receptor 3 on endothelial function and infection.
wb		Santa Cruz Biotechnology anti-phosphoERK antibody was used in western blot to study the pathway for platelet-derived growth factor to induce the beta-gamma-secretase-mediated cleavage of alzheimer's amyloid precursor protein.
wb		Santa Cruz Biotechnology Phospho-ERK1/2 mAb and ERK2 polyclonal Ab were used in western blot to study the effect of leukocyte-endothelium interaction on SDF-1-dependent polarization of CXCR4.
wb		Santa Cruz Biotechnology affinity-purified rabbit polyclonal antibody against Erk-2 was used in western blot to study the Initiation of CD38 signaling in T Cells within a subset of membrane rafts containing Lck and the CD3-zeta subunit of the T cell antigen receptor.
wb		Santa Cruz antibody against extracellular signal-regulated kinase 2 was used in western blot to investigate the consequences of Xrcc3 overexpression in terms of cell cycle progression, Rad51-related homologous recombinational repair, and cell survival after cisplatin treatment in the breast cancer cell line MCF-7.
wb		Santa Cruz Biotechnology anti-Erk antibody was used in western blot to study the effect of receptor-type protein-tyrosine phosphatase-κ on epidermal growth factor receptor function.
wb		Santa Cruz Biotechnology anti-ERK2 antibody C14 was used in western blot to study the interaction of Bcr kinase and AF-6 and the effects of them on Ras signaling.
wb		Santa Cruz Biotechnology monoclonal anti-Erk2 antibody was used in western blot to detect Erk2 as a loading control in LNCaP cells with FKHR transfection.
wb		Santa Cruz Biotechnology anti-total and phospho-ERK2 antibody was used in western blot to detect total and phospho-ERK2 in human B lymphoma cell line ramos 2G6 incubated with anti-CD45, following stimulated by IL-4 and anti-CD40.
wb		Santa Cruz Biotechnology mouse polyclonal anti-phospho-p42 MAPK antibody was used in western blot to detect the phospho-p42 MAPK in differentiated and non-differentiated N1E-115-NT1-EGFP cells stimulated with no agonist or JMV 449.
wb		Santa Cruz rabbit anti-total ERK2 antibody was used in western blot to detect total ERK2 in PAK4 knockdown (RNAi) cells untreated or treated with TNFalpha+CHX.
wb		Santa Cruz Biotechnology anti-ERK2 antibody was used in mouse R cells (which was transfected with plasmids containing human cDNAs.) and in western blot to study the contributions of the different downstream pathways of IGF-IR to IGF-IR-mediated radioresistance.
wb		Santa Cruz Biotechnologies antibody that recognizes total ERK1/2 (clone K-23) was used in western blot to investigate the activation of ERK1/2 in primary human melanocytes isolated from neonatal foreskins and in the human melanoma SK-MEL-24 and SK-MEL-28 cell lines.
wb		Santa Cruz Biotechnology rabbit polyclonal anti-ERK2 antibody was used in western blot to detect ERK2 in NIH 3T3 cells transiently transfected with vector, RACK1, or mutant RACK1 and HEK 293 cells transfected with RACK1 siRNAs.
wb		Santa Cruz Biotechnologies monoclonal anti-phospho-ERK and polyclonal anti-ERK2 antibodies were used in human umbilical vein endothelial cells (HUVECs) and in western blot to study the effect of enhanced p38 MAPK activity on endothelial cell function.
wb		Santa Cruz Biotechnology mouse monoclonal anti-p42 MAPK antibody was used in thyroid TAD-2 cells and the hepatoma cell line Hep3B and in western blot to study the interaction of calcium/calmodulin-dependent protein kinase II with Raf-1 and the effect of it on integrin-stimulated ERK activation.
wb		Santa Cruz Biotechnology polyclonal antisera against ERK2 was used in western blot to detect ERK2 expression levels in human HepG2 cells.
wb		Santa Cruz Biotechnology anti-extracellular signal-regulated kinase 2 antibody was used in western blot to detect extracellular signal-regulated kinase 2 in Panc-1 cells.
wb		Santa Cruz Biotechnology mouse anti-phospho-ERK (E4) was used in western blot to detect the amount of phospho-Erk in mouse Ba/F3 cells and human Hep3B cells.
wb		Santa Cruz Biotechnology anti-ERK antibody was used in western blot to detect ERK in human orbital fibroblasts.
wb		Santa Cruz Biotechnology polyclonal anti-ERK2 antibody was used in western blot to detect ERK2 in A549 cells.
wb		Santa Cruz Biotechnology anti-ERK2 antibody was used in western blot to detect ERK2 in D5 and vector HEK293 cells untreated or treated with insulin.
wb		Santa Cruz Biotechnology anti-ERK and phosphorylated ERK antibody was used in western blot to detect ERK and phosphorylated ERK in HepG2 cells expressing CYP2E1 or CYP3A4.
wb		Santa Cruz Biotechnology polyclonal anti-ERK2 antibody was used in human A549 cells and in western blot to study the interaction between the receptor protein-tyrosine phosphatase PTPµ and IQGAP1.
wb		Santa Cruz Biotechnology rabbit polyclonal anti-Erk2 antibody (C-14) was used in human 293T cells and in western blot to study the effect of RET/PTC3 on the Erk8 mitogen-activated protein (MAP) kinase.
wb		Santa Cruz Biotechnology anti-ERK2 antibody was used in human H295R cells and in western blot to study the roles of Janus kinase 2 and calcium for angiotensin II-dependent activation of steroidogenic acute regulatory protein transcription in H295R human adrenocortical cells.
wb		Santa Cruz Biotechnology monoclonal anti-phospho-ERK and polyclonal anti-ERK were used in western blot to study the physiological role of ER palmitoylation in the receptor localization to the cell membrane and in the regulation of the E2-induced cell proliferation.
wb		Santa Cruz anti-ERK2 antibody (C-14) was used in human HeLa cells and in western blot to study the effect of multiple protein kinases and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription on constitutive and interleukin-1-inducible phosphorylation of p65 NF- B at serine 536.
wb		Santa Cruz Biotechnology anti-ERK1/2 was used in western blot to detect ERK1/2 in A2780 and OVCAR5 ovarian cancer cell lines and human HEK293 cells.
wb		Santa Cruz Biotechnology rabbit polyclonal anti-ERK2 antibody (K-23) was used in human NK92 cells and in western blot to study the role for the interleukins 2 and 15 in regulating Ets1 expression in human natural killer cells.
wb		Santa Cruz Biotechnology anti-ERK antibody was used in human HEK293T cells and in western blot to study the antagonizing of the receptor-type protein tyrosine phosphatase J for effects of RET-derived oncoproteins.
wb		Santa Cruz Biotechnology anti-ERK2 antibody was used in human cells (HT1080 fibrosarcoma, A375 melanoma, RD rhabdomyosarcoma cells) and in western blot to study the role for integrins in regulating the apoptotic response to DNA damage.
wb		Santa Cruz Biotechnology anti-p-ERK1/2 (sc-7383) and anti-ERK-2 (sc-1647) antibodies were used in Western blot to study the biological function of TRAIL induced apoptosis in human colon cells.
wb		Santa Cruz Biotechnology rabbit affinity-purified IgG to ERK2 was used in western blot in the study of fibronectin protecting prostate cancer cells from tumor necrosis factor-alpha-induced aoptosis via the AKT/Survivin pathway.
wb		Santa Cruz Biotechnologies polyclonal anti-ERK2 antibody was used in western blot to study the GIPC interaction with beta1-adrenergic receptor and its regulation on beta1-adrenergic receptor-mediated ERK activation.
wb		Santa Cruz Biotechnology anti-ERK2 antibody (sc-154) was used in western blot to study the physical interaction between Runx2 and Stat3β enhanced by GH and downregulateing the transcriptional properties of this key osteogenic regulator.
wb		Santa Cruz Biotechnology mouse monoclonal anti-ERK2 antibody and rabbit anti-phospho-ERK1/2 antibodies were used in western blot to study the role of uPAR in cross-talk between FPR and alphavbeta5.
wb		Santa Cruz Biotechnology rabbit anti-p42/44 MAPK antibody was used in western blot to study the protective role of SCP and SRP against hypoxia/rexygenation injury in rat neonatal cardiomyocytes.
wb		The txt can be:Santa Cruz anti-ERK2 antibody was used in western blot to study the fuction of pancreatic bile salt-dependent lipase to induce smooth muscle cells proliferation.
wb		Santa Cruz Biotechnology ERK1/2 rabbit polyclonal antibody was used in western blot to study the inhibition of matrix metalloproteinase-9 expression by ascochlorin.
wb		Santa Cruz Biotechnology anti-ERK and anti-p-ERK antibodies were used in western blot to study the immortalization of bovine lens epithelial cells by human telomerase reverse transcriptase.
wb		Santa Cruz Biotechnology anti-p38 MAP kinase antibody was used in western blot to study ERK2 and p38 involvement in platelet adhesion to collagen.
wb		Santa Cruz Biotechnologies Erk2 antibody was used in western blot to study COLO-357 cell growth inhibition by TGF beta1.
R & D SYSTEMS search R & D Systems MAPK1 products includes other brands or spellings
wb		R & D Systems rabbit phospho-ERK1/ERK2 (T202/Y204) antibody was used in western blot to study rRNA transcription regulation by fibroblast growth factor 2.
BD BIOSCIENCES search BD Biosciences MAPK1 products includes other brands or spellings
ic, wb		Transduction Laboratories anti-phospho-ERK1/2 (Thr202/Tyr204, P-ERK1/2) antibody was used in western blot and immunocytochemistry to study estrogen receptor alpha modulation in breast cancer cells.
wb		BD Transduction ERK (pan ERK) antibody was tested in western blot by Abminer.
wb		Transduction Laboratories ERK1/2 antibody was used in western blot to study insulin receptor catalytic activity inhibition.
wb		BD Biosciences anti-ERK2 monoclonal antibody was used in western blot to identify DUSP6 as one of the key players in the tumor suppressive pathway and as a promising molecular target for curing patients with pancreatic cancer.
wb		Transduction Laboratories monoclonal anti-extracellular signal-regulated kinase 2 antibody was used in western blot to study that induction of disease-associated keratin 16 gene expression by epidermal growth factor is regulated through cooperation of transcription factors Sp1 and c-Jun.
wb		BD Transduction Laboratories anti-Erk2 antibody was used in western blot to study SHPS-1 in the regulation of insulin-like growth factor I which stimulated Shc and mitogen-activated protein kinase activation in vascular smooth muscle cells.
wb		Transduction Laboratories monoclonal anti-total ERK (clone 16) was used in Western blot to study the role of PPARgamma and EGFR signalling.
wb		BD Biosciences mouse anti-Erk2 antibody was used in western blot to characterize lymphangiogenic vascular endothelial growth factors VEGF-C and -D.
wb		Transduction Laboratories anti-ERK-2 antibody was used in western blot to study a potential role for tyrosine phosphatases.
wb		BD Biosciences rabbit anti-ERK2 antibody was used in western blot to study the convergence of cell cycle regulation and growth factor signals on GRASP65.
MILLIPORE search Millipore MAPK1 products includes other brands or spellings
wb		Upstate Biotechnology anti-total p42 MAPK antibody was used in western blot to detect the total p42 MAPK in differentiated and non-differentiated N1E-115-NT1-EGFP cells stimulated with no agonist or JMV 449.
wb		Upstate Biotechnology monoclonal anti-Erk2 antibody was used in human MCF-7 cells (which were ransfected with plasmids encoding HA-RACK1) and in western blot to study the role for the interaction between RACK1 and insulin-like growth factor 1 (IGF-1) receptor in regulating IGF-1-mediated Akt activation and protection from cell death.
wb		Upstate Biotechnology anti-ERK antibody was used in western blot to detect ERK expression in human A549 lung adenocarcinoma cells.
wb		Upstate Biotechnology monoclonal anti-ERK2 antibody was used in western blot to dissect the basis of nongenomic activation of endothelial nitric oxide synthase by estradiol.
INVITROGEN search Invitrogen MAPK1 products includes other brands or spellings
ic, wb		Zymed ERK1/2 monoclonal antibody was used in immunocytochemistry to investigate the role of GIT1 in ERK1/2 activation during focal adhesions.
ic		BIOSOURCE phospho-ERK1/2 antibody was used in immunocytochemistry to detect the localization of activated ERK1/2 in human melanoma SK-MEL-28 cells.
wb		BioSource anti-ERK1/2 and anti-phospho-ERK1/2 antibodies were used in western blot to study SP/NK1R-induced cell death mediated by a MAP kinase activation pathway involving Raf-1, MEK2, and extracellular signal-regulated protein kinase 2 (ERK2).
wb		Zymed Laboratories anti-total ERK polyclonal antibody was used in western blot to study the mitogenic activity of urokinase-type plasminogen activator which is determined by the dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex.
wb		BIOSOURCE rabbit polyclonal anti-Erk1/2 pTpY185/187 antibody was used in western blot to characterize lymphangiogenic vascular endothelial growth factors VEGF-C and -D.
THERMO FISHER SCIENTIFIC search Thermo Fisher Scientific MAPK1 products includes other brands or spellings
wb		Neomarkers anti-ERK1/2 antibody was used in western blot to study estrogen receptor alpha modulation in breast cancer cells.
GE HEALTHCARE LIFE BIOSCIENCES search GE Healthcare Life Biosciences MAPK1 products includes other brands or spellings
wb		Amersham Biosciences ERK and phospho-ERK (Thr202/Tyr204) antibodies were used in western blot to detect ERK and phosphorylated ERK respectively in human HEK 293 cells.
PROMEGA search Promega MAPK1 products
wb		Promega anti-ERK antibody was used in western blot to study the effects of TL1A-induced NF- B and c-IAP2 on DR3-mediated apoptosis in TF-1 cells.
wb		Promega polyclonal phosphorylated ERK1/2 antibody was used in western blot to study insulin receptor catalytic activity inhibition.
wb		Promega anti-active MAPK (ERK1/2) antibody was used in western blot to study the inhibitory effects of galanin receptor 1 on proliferation in oral squamous cell carcinoma.
wb		Promega anti-ERK2 antibody was used in western blot to detect ERK2 in 3T3-L1 cells infected with a retrovirus carrying the gene for C/EBPalpha.
wb		Promega anti-phospho-extracellular signal-regulated kinase 2 antibody was used in western blot to detect phospho-extracellular signal-regulated kinase 2 in Panc-1 cells.
wb		Promega anti-doubly phosphorylated ERK antibody was used in western blot to detect ERK phosphorylation status in human A549 lung adenocarcinoma cells.
wb		Promega polyclonal anti-phospho-erk (perk) antibody was used in western blot to dissect the basis of nongenomic activation of endothelial nitric oxide synthase by estradiol.
wb		Promega anti-phospho-ERK antibody was used in western blot to study the induction of neuroblastoma cell apoptosis by TrkA.
wb		Promega rabbit anti-pERK polyclonal antibody was used in western blot to study the convergence of cell cycle regulation and growth factor signals on GRASP65.
wb		Promega antibody against the phosphorylated p38 MAP kinase was used in western blot to study ERK2 and p38 involvement in platelet adhesion to collagen.
wb		Promega phospho-specific MAPK antibody was used in western blot to study COLO-357 cell growth inhibition by TGF beta1.
QCB
wb		QCB rabbit anti-phospho-ERK2 polyclonal antibody was used in western blot to study the frequent co-Localization of cox-2 and laminin-5 2 chain at the invasive front of early-stage lung adenocarcinomas.
SANTA CRUZ INC
wb		Santa Cruz Inc anti-p42MAPK antibody was used in human MCF-7 cells and in western blot to study the effects of insulin-like growth factor-binding protein-3 on the IGF-I signaling pathway.

Articles Reviewed

1. Veronique BÃ©rÃ©ziat et al. Inhibition of insulin receptor catalytic activity by the molecular adapter Grb14. 2002

2. Chunrong Yu et al. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells. 2002

3. Haikun Shi et al. Interactions of beta and gamma ENaC with Nedd4 can be facilitated by an ERK-mediated phosphorylation. 2002

4. Tara Ann Santore et al. Adenovirus-directed expression of Q227L-G alpha(s) inhibits growth of established tumors of later-stage human breast cancer cells in athymic mice. 2002

5. Rui Han et al. Up-regulation of prostaglandin E2 synthesis by interleukin-1beta in human orbital fibroblasts involves coordinate induction of prostaglandin-endoperoxide H synthase-2 and glutathione-dependent prostaglandin E2 synthase expression. 2002

6. Toshifumi Fukuda et al. Novel mechanism of regulation of Rac activity and lamellipodia formation by RET tyrosine kinase. 2002

7. Toshiro Niki et al. Frequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas. 2002

8. Jianguo Gu et al. Laminin-10/11 and fibronectin differentially prevent apoptosis induced by serum removal via phosphatidylinositol 3-kinase/Akt- and MEK1/ERK-dependent pathways. 2002

9. Ye Zhang et al. RANTES-mediated chemokine transcription in astrocytes involves activation and translocation of p90 ribosomal S6 protein kinase (RSK). 2002

10. Jean McArthur Lewis et al. Integrins regulate the apoptotic response to DNA damage through modulation of p53. 2002

11. Junfang Wu et al. Attenuation of protein kinase C and cAMP-dependent protein kinase signal transduction in the neurogranin knockout mouse. 2002

12. Hiroyuki Sano et al. Insulin receptor substrate 4 associates with the protein IRAS. 2002

13. Armelle Yart et al. A function for phosphoinositide 3-kinase beta lipid products in coupling beta gamma to Ras activation in response to lysophosphatidic acid. 2002

14. Xiaodan Yu et al. Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228. 2002

15. Dayanand D Deo et al. Phosphorylation of STAT-3 in response to basic fibroblast growth factor occurs through a mechanism involving platelet-activating factor, JAK-2, and Src in human umbilical vein endothelial cells. Evidence for a dual kinase mechanism. 2002

16. Jean-Marc Ricort et al. Insulin-like growth factor-binding protein-3 activates a phosphotyrosine phosphatase. Effects on the insulin-like growth factor signaling pathway. 2002

17. Vyacheslav Yurchenko et al. Active site residues of cyclophilin A are crucial for its signaling activity via CD147. 2002

18. Shazli N Malik et al. Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer. 2002

19. Wai K Wong et al. Activation of human monoamine oxidase B gene expression by a protein kinase C MAPK signal transduction pathway involves c-Jun and Egr-1. 2002

20. Patrick A Kiely et al. RACK1 is an insulin-like growth factor 1 (IGF-1) receptor-interacting protein that can regulate IGF-1-mediated Akt activation and protection from cell death. 2002

21. Christine Guntermann et al. CTLA-4 suppresses proximal TCR signaling in resting human CD4(+) T cells by inhibiting ZAP-70 Tyr(319) phosphorylation: a potential role for tyrosine phosphatases. 2002

22. Bernardo Yusta et al. Glucagon-like peptide-2 receptor activation engages bad and glycogen synthase kinase-3 in a protein kinase A-dependent manner and prevents apoptosis following inhibition of phosphatidylinositol 3-kinase. 2002

23. Takechiyo Yamada et al. CD45 controls interleukin-4-mediated IgE class switch recombination in human B cells through its function as a Janus kinase phosphatase. 2002

24. Maryse Delehedde et al. Fibroblast growth factor-2 binds to small heparin-derived oligosaccharides and stimulates a sustained phosphorylation of p42/44 mitogen-activated protein kinase and proliferation of rat mammary fibroblasts. 2002

25. Marcus Buschbeck et al. Phosphotyrosine-specific phosphatase PTP-SL regulates the ERK5 signaling pathway. 2002

26. Elena DÃaz-RodrÃguez et al. Extracellular signal-regulated kinase phosphorylates tumor necrosis factor alpha-converting enzyme at threonine 735: a potential role in regulated shedding. 2002

27. Shengzhan Luo et al. Requirement of the p38 mitogen-activated protein kinase signalling pathway for the induction of the 78 kDa glucose-regulated protein/immunoglobulin heavy-chain binding protein by azetidine stress: activating transcription factor 6 as a target for stress-i. 2002

28. Mei-Ren Pan et al. Nonsteroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 via suppression of the ERK/Sp1-mediated transcription. 2002

29. Hideki Murakami et al. Role of Dok1 in cell signaling mediated by RET tyrosine kinase. 2002

30. Mihail S Iordanov et al. The UV (Ribotoxic) stress response of human keratinocytes involves the unexpected uncoupling of the Ras-extracellular signal-regulated kinase signaling cascade from the activated epidermal growth factor receptor. 2002

31. Zhong-Zong Pan et al. Gamma-synuclein promotes cancer cell survival and inhibits stress- and chemotherapy drug-induced apoptosis by modulating MAPK pathways. 2002

32. Giuseppe Pandini et al. Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved. 2002

33. Catherine Lavoie et al. Beta 1/beta 2-adrenergic receptor heterodimerization regulates beta 2-adrenergic receptor internalization and ERK signaling efficacy. 2002

34. Laurie M Zipper et al. The Keap1 BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm. 2002

35. John K G Crean et al. The role of p42/44 MAPK and protein kinase B in connective tissue growth factor induced extracellular matrix protein production, cell migration, and actin cytoskeletal rearrangement in human mesangial cells. 2002

36. Evelina Grantcharova et al. The extracellular N terminus of the endothelin B (ETB) receptor is cleaved by a metalloprotease in an agonist-dependent process. 2002

37. Jena J Steinle et al. Eph B4 receptor signaling mediates endothelial cell migration and proliferation via the phosphatidylinositol 3-kinase pathway. 2002

38. Yue Sun et al. Beta-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation. 2002

39. Baoxue Ge et al. TAB1beta (transforming growth factor-beta-activated protein kinase 1-binding protein 1beta ), a novel splicing variant of TAB1 that interacts with p38alpha but not TAK1. 2003

40. Christina Kast et al. The ERK/MAPK pathway regulates the activity of the human tissue factor pathway inhibitor-2 promoter. 2003

41. Yong-Dae Kim et al. Interleukin-1beta induces MUC2 gene expression and mucin secretion via activation of PKC-MEK/ERK, and PI3K in human airway epithelial cells. 2002

42. Dong Yu et al. Redundancy of radioresistant signaling pathways originating from insulin-like growth factor I receptor. 2003

43. Pramod P Naranatt et al. Kaposi's sarcoma-associated herpesvirus induces the phosphatidylinositol 3-kinase-PKC-zeta-MEK-ERK signaling pathway in target cells early during infection: implications for infectivity. 2003

44. Tiho Miralem et al. Extracellular matrix enhances heregulin-dependent BRCA1 phosphorylation and suppresses BRCA1 expression through its C terminus. 2003

45. Yong Zhu et al. Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes. 2003

46. Fuminori Umenishi et al. Hypertonicity-induced aquaporin-1 (AQP1) expression is mediated by the activation of MAPK pathways and hypertonicity-responsive element in the AQP1 gene. 2003

47. Stephan Schiekofer et al. Acute hyperglycemia causes intracellular formation of CML and activation of ras, p42/44 MAPK, and nuclear factor kappaB in PBMCs. 2003

48. Malvyne Rolli-Derkinderen et al. ERK and p38 inhibit the expression of 4E-BP1 repressor of translation through induction of Egr-1. 2003

49. Ursula G B Haider et al. Resveratrol increases serine15-phosphorylated but transcriptionally impaired p53 and induces a reversible DNA replication block in serum-activated vascular smooth muscle cells. 2003

50. Davide Gianni et al. Platelet-derived growth factor induces the beta-gamma-secretase-mediated cleavage of Alzheimer's amyloid precursor protein through a Src-Rac-dependent pathway. 2003

51. DiAnna L Hynds et al. Rit promotes MEK-independent neurite branching in human neuroblastoma cells. 2003

52. Liaoyuan A Hu et al. GIPC interacts with the beta1-adrenergic receptor and regulates beta1-adrenergic receptor-mediated ERK activation. 2003

53. Dongsheng Cai et al. Two new substrates in insulin signaling, IRS5/DOK4 and IRS6/DOK5. 2003

54. Toru Furukawa et al. Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer. 2003

55. Jaap D van Buul et al. Leukocyte-endothelium interaction promotes SDF-1-dependent polarization of CXCR4. 2003

56. Pengfei Gong et al. Increased expression of cytochrome P450 2E1 induces heme oxygenase-1 through ERK MAPK pathway. 2003

57. G Radziwill et al. The Bcr kinase downregulates Ras signaling by phosphorylating AF-6 and binding to its PDZ domain. 2003

58. Audrey Robinson-White et al. Protein kinase-A activity in PRKAR1A-mutant cells, and regulation of mitogen-activated protein kinases ERK1/2. 2003

59. Nathalie AugÃ© et al. Pancreatic bile salt-dependent lipase induces smooth muscle cells proliferation. 2003

60. Sean R Conner et al. Adhesion-dependent activation of the ERK1/2 cascade is by-passed in melanoma cells. 2003

61. Heather M Wilcox et al. Itk phosphorylation sites are required for functional activity in primary T cells. 2003

62. Yuichi Oike et al. Angiopoietin-related growth factor (AGF) promotes epidermal proliferation, remodeling, and regeneration. 2003

63. Leng Wen et al. TL1A-induced NF-kappaB activation and c-IAP2 production prevent DR3-mediated apoptosis in TF-1 cells. 2003

64. Ying-Nai Wang et al. Induction of disease-associated keratin 16 gene expression by epidermal growth factor is regulated through cooperation of transcription factors Sp1 and c-Jun. 2003

65. Maddalena Illario et al. Calcium/calmodulin-dependent protein kinase II binds to Raf-1 and modulates integrin-stimulated ERK activation. 2003

66. Min Zhou et al. Interferon-gamma differentially regulates monocyte matrix metalloproteinase-1 and -9 through tumor necrosis factor-alpha and caspase 8. 2003

67. Gary S Goldberg et al. Src phosphorylates Cas on tyrosine 253 to promote migration of transformed cells. 2003

68. A Chanalaris et al. Protective effects of the urocortin homologues stresscopin (SCP) and stresscopin-related peptide (SRP) against hypoxia/reoxygenation injury in rat neonatal cardiomyocytes. 2003

69. Pilar MuÃ±oz et al. CD38 signaling in T cells is initiated within a subset of membrane rafts containing Lck and the CD3-zeta subunit of the T cell antigen receptor. 2003

70. Mara Fornaro et al. Fibronectin protects prostate cancer cells from tumor necrosis factor-alpha-induced apoptosis via the AKT/survivin pathway. 2003

71. Yu-Wen Zhang et al. Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation. 2003

72. Noriyuki Ouchi et al. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. 2004

73. Jianghong Li et al. Janus kinase 2 and calcium are required for angiotensin II-dependent activation of steroidogenic acute regulatory protein transcription in H295R human adrenocortical cells. 2003

74. Martha M Monick et al. Respiratory syncytial virus up-regulates TLR4 and sensitizes airway epithelial cells to endotoxin. 2003

75. Geqiang Li et al. An apoptotic signaling pathway in the interferon antiviral response mediated by RNase L and c-Jun NH2-terminal kinase. 2004

76. Emmanouil Karteris et al. Urocortin II is expressed in human pregnant myometrial cells and regulates myosin light chain phosphorylation: potential role of the type-2 corticotropin-releasing hormone receptor in the control of myometrial contractility. 2004

77. Woojin Jeong et al. Roles of TRP14, a thioredoxin-related protein in tumor necrosis factor-alpha signaling pathways. 2004

78. Mireille Toy-Miou-Leong et al. Receptor trafficking via the perinuclear recycling compartment accompanied by cell division is necessary for permanent neurotensin cell sensitization and leads to chronic mitogen-activated protein kinase activation. 2004

79. Sarah E Ross et al. Phosphorylation of C/EBPalpha inhibits granulopoiesis. 2004

80. Yingzi Yue et al. Ras GTPase-activating protein binds to Akt and is required for its activation. 2004

81. Haojie Huang et al. Androgens negatively regulate forkhead transcription factor FKHR (FOXO1) through a proteolytic mechanism in prostate cancer cells. 2004

82. Akihiro Iwabu et al. Epidermal growth factor induces fibroblast contractility and motility via a protein kinase C delta-dependent pathway. 2004

83. Susana Castro-ObregÃ³n et al. Alternative, nonapoptotic programmed cell death: mediation by arrestin 2, ERK2, and Nur77. 2004

84. Olin D Liang et al. Oncodevelopmental alpha-fetoprotein acts as a selective proangiogenic factor on endothelial cell from the fetomaternal unit. 2004

85. Saveria Aquila et al. Estrogen receptor (ER)alpha and ER beta are both expressed in human ejaculated spermatozoa: evidence of their direct interaction with phosphatidylinositol-3-OH kinase/Akt pathway. 2004

86. Kristina Holmqvist et al. The adaptor protein shb binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-dependent cellular migration. 2004

87. Xu Shi-Wen et al. Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. 2004

88. Claire L Varley et al. Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme. 2004

89. Lubna Al-Khalili et al. ERK1/2 mediates insulin stimulation of Na(+),K(+)-ATPase by phosphorylation of the alpha-subunit in human skeletal muscle cells. 2004

90. Yasuhiro Imamura et al. Identification and characterization of a novel BASH N terminus-associated protein, BNAS2. 2004

91. Julien Mazieres et al. Loss of RhoB expression in human lung cancer progression. 2004

92. Shinji Yamamoto et al. Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma. 2004

93. Sunryeo Beom et al. Comparative studies of molecular mechanisms of dopamine D2 and D3 receptors for the activation of extracellular signal-regulated kinase. 2004

94. Zhibo Yang et al. Human epidermal growth factor receptor 2 status modulates subcellular localization of and interaction with estrogen receptor alpha in breast cancer cells. 2004

95. Silvestre Vicent et al. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients. 2004

96. Masaru Mitsushima et al. Extracellular signal-regulated kinase activated by epidermal growth factor and cell adhesion interacts with and phosphorylates vinexin. 2004

97. Matthew Wherlock et al. Farnesyltransferase inhibitors disrupt EGF receptor traffic through modulation of the RhoB GTPase. 2004

98. Vidya Mamidipudi et al. RACK1 regulates G1/S progression by suppressing Src kinase activity. 2004

99. Md Ruhul Abid et al. Vascular endothelial growth factor-mediated induction of manganese superoxide dismutase occurs through redox-dependent regulation of forkhead and IkappaB/NF-kappaB. 2004

100. Melanie Keiper et al. Epac- and Ca2+ -controlled activation of Ras and extracellular signal-regulated kinases by Gs-coupled receptors. 2004

101. Joao T Barata et al. Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells. 2004

102. Lijun Xu et al. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induces phosphorylation of mu- and m-calpain in association with increased secretion, cell migration, and invasion. 2004

103. Panos G Ziros et al. Growth hormone attenuates the transcriptional activity of Runx2 by facilitating its physical association with Stat3beta. 2004

104. Andrew M F Liu et al. G16-mediated activation of nuclear factor kappaB by the adenosine A1 receptor involves c-Src, protein kinase C, and ERK signaling. 2004

105. Ken L Chambliss et al. Dissecting the basis of nongenomic activation of endothelial nitric oxide synthase by estradiol: role of ERalpha domains with known nuclear functions. 2005

106. Holger Buss et al. Constitutive and interleukin-1-inducible phosphorylation of p65 NF-{kappa}B at serine 536 is mediated by multiple protein kinases including I{kappa}B kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF family member-associated (TANK)-binding kinase 1 (TBK. 2004

107. Filippo Acconcia et al. Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol. 2005

108. Mark E Williams et al. Ric-3 promotes functional expression of the nicotinic acetylcholine receptor alpha7 subunit in mammalian cells. 2005

109. Nikolaos A Tountas et al. Migration and retraction of endothelial and epithelial cells require PHI-1, a specific protein-phosphatase-1 inhibitor protein. 2004

110. Eric M Grund et al. Interleukins 2 and 15 regulate Ets1 expression via ERK1/2 and MNK1 in human natural killer cells. 2005

111. Nicholas E Vlahakis et al. The lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin alpha9beta1. 2005

112. Wei Wu et al. Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival. 2005

113. Ling-Chi Wang et al. Tumor necrosis factor alpha-dependent drug resistance to purine and pyrimidine analogues in human colon tumor cells mediated through IKK. 2005

114. Patrick A Kiely et al. RACK1-mediated integration of adhesion and insulin-like growth factor I (IGF-I) signaling and cell migration are defective in cells expressing an IGF-I receptor mutated at tyrosines 1250 and 1251. 2005

115. Guru Dutt Sharma et al. Epidermal and hepatocyte growth factors, but not keratinocyte growth factor, modulate protein kinase Calpha translocation to the plasma membrane through 15(S)-hydroxyeicosatetraenoic acid synthesis. 2005

116. Carolyn M Klinge et al. Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells. 2005

117. Hee Yun et al. Glucose deprivation increases mRNA stability of vascular endothelial growth factor through activation of AMP-activated protein kinase in DU145 prostate carcinoma. 2005

118. Dominic De Nardo et al. A central role for the Hsp90.Cdc37 molecular chaperone module in interleukin-1 receptor-associated-kinase-dependent signaling by toll-like receptors. 2005

119. Akihiko Numata et al. Signal transducers and activators of transcription 3 augments the transcriptional activity of CCAAT/enhancer-binding protein alpha in granulocyte colony-stimulating factor signaling pathway. 2005

120. Ilchung Shin et al. H-Ras-specific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells. 2005

121. Hubert Robitaille et al. The mitogen-activated protein kinase kinase kinase dual leucine zipper-bearing kinase (DLK) acts as a key regulator of keratinocyte terminal differentiation. 2005

122. Nancy Gavert et al. L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. 2005

123. Minji Jo et al. Dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex determines the mitogenic activity of urokinase-type plasminogen activator. 2005

124. Christophe F Deroanne et al. Cdc42 downregulates MMP-1 expression by inhibiting the ERK1/2 pathway. 2005

125. Jean S Campbell et al. Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. 2005

126. Laura Suomalainen et al. Sphingosine-1-phosphate inhibits nuclear factor kappaB activation and germ cell apoptosis in the human testis independently of its receptors. 2005

127. Rinat Arbel-Goren et al. Cyclin-dependent kinase inhibitors and JNK act as molecular switches, regulating the choice between growth arrest and apoptosis induced by galectin-8. 2005

128. Konstantinos G Drosopoulos et al. Transformation by oncogenic RAS sensitizes human colon cells to TRAIL-induced apoptosis by up-regulating death receptor 4 and death receptor 5 through a MEK-dependent pathway. 2005

129. Scott K Kuwada et al. Integrin alpha5/beta1 expression mediates HER-2 down-regulation in colon cancer cells. 2005

130. Bradley S Henson et al. Galanin receptor 1 has anti-proliferative effects in oral squamous cell carcinoma. 2005

131. Ho Kim et al. Clostridium difficile toxin A regulates inducible cyclooxygenase-2 and prostaglandin E2 synthesis in colonocytes via reactive oxygen species and activation of p38 MAPK. 2005

132. Meghan E McMullen et al. Activation of p38 has opposing effects on the proliferation and migration of endothelial cells. 2005

133. Apostolos Polykratis et al. Characterization of heparin affin regulatory peptide signaling in human endothelial cells. 2005

134. Nichole Boyer Arnold et al. Smad7 abrogates transforming growth factor-beta1-mediated growth inhibition in COLO-357 cells through functional inactivation of the retinoblastoma protein. 2005

135. Shin-ichiro Yoshimura et al. Convergence of cell cycle regulation and growth factor signals on GRASP65. 2005

136. Xiaoping Chen et al. Dedifferentiation of adult human myoblasts induced by ciliary neurotrophic factor in vitro. 2005

137. Zhi-Yuan Xu et al. Xrcc3 induces cisplatin resistance by stimulation of Rad51-related recombinational repair, S-phase checkpoint activation, and reduced apoptosis. 2005

138. Algirdas Ziogas et al. CNK1 is a scaffold protein that regulates Src-mediated Raf-1 activation. 2005

139. Juan Wang et al. Human telomerase reverse transcriptase immortalizes bovine lens epithelial cells and suppresses differentiation through regulation of the ERK signaling pathway. 2005

140. Shenghao Jin et al. p21-activated Kinase 1 (Pak1)-dependent phosphorylation of Raf-1 regulates its mitochondrial localization, phosphorylation of BAD, and Bcl-2 association. 2005

141. Alexandra Mazharian et al. Differential Involvement of ERK2 and p38 in platelet adhesion to collagen. 2005

142. SaHyun Hong et al. Ascochlorin inhibits matrix metalloproteinase-9 expression by suppressing activator protein-1-mediated gene expression through the ERK1/2 signaling pathway: inhibitory effects of ascochlorin on the invasion of renal carcinoma cells. 2005

143. Lucia Gargiulo et al. Cross-talk between fMLP and vitronectin receptors triggered by urokinase receptor-derived SRSRY peptide. 2005

144. Xuefeng Zhang et al. Kaposi's sarcoma-associated herpesvirus activation of vascular endothelial growth factor receptor 3 alters endothelial function and enhances infection. 2005

145. Yan Ling et al. Role of SHPS-1 in the regulation of insulin-like growth factor I-stimulated Shc and mitogen-activated protein kinase activation in vascular smooth muscle cells. 2005

146. Frederic D Sigoillot et al. Nuclear localization and mitogen-activated protein kinase phosphorylation of the multifunctional protein CAD. 2005

147. N A C S Wong et al. CDX1 is an important molecular mediator of Barrett's metaplasia. 2005

148. Guoyong Yin et al. GIT1 is a scaffold for ERK1/2 activation in focal adhesions. 2005

149. Ye Zhou et al. Formylpeptide receptor FPR and the rapid growth of malignant human gliomas. 2005

150. Christopher S Newton et al. Platelet-derived growth factor receptor-beta (PDGFR-beta) activation promotes its association with the low density lipoprotein receptor-related protein (LRP). Evidence for co-receptor function. 2005

151. Rentian Feng et al. Inhibition of activator protein-1, NF-kappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. 2005

152. Jean-FranÃ§ois Lavoie et al. TrkA induces apoptosis of neuroblastoma cells and does so via a p53-dependent mechanism. 2005

153. Nikos Tapinos et al. Insights into regulation of human Schwann cell proliferation by Erk1/2 via a MEK-independent and p56Lck-dependent pathway from leprosy bacilli. 2005

154. Alex C Minella et al. Ras activity regulates cyclin E degradation by the Fbw7 pathway. 2005

155. Margrit Hollborn et al. Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF. 2005

156. Martin J Lynch et al. RNA silencing identifies PDE4D5 as the functionally relevant cAMP phosphodiesterase interacting with beta arrestin to control the protein kinase A/AKAP79-mediated switching of the beta2-adrenergic receptor to activation of ERK in HEK293B2 cells. 2005

157. Charles E Ducker et al. Two N-myristoyltransferase isozymes play unique roles in protein myristoylation, proliferation, and apoptosis. 2005

158. Yuemeng Dai et al. HSulf-1 and HSulf-2 are potent inhibitors of myeloma tumor growth in vivo. 2005

159. Rama Soundararajan et al. A novel role for glucocorticoid-induced leucine zipper protein in epithelial sodium channel-mediated sodium transport. 2005

160. Ryuichi Mashima et al. FLN29, a novel interferon- and LPS-inducible gene acting as a negative regulator of toll-like receptor signaling. 2005

161. Zhi Sheng et al. Direct regulation of rRNA transcription by fibroblast growth factor 2. 2005

162. Xiaofan Li et al. PAK4 functions in tumor necrosis factor (TNF) alpha-induced survival pathways by facilitating TRADD binding to the TNF receptor. 2005

163. Yiru Xu et al. Receptor-type protein-tyrosine phosphatase-kappa regulates epidermal growth factor receptor function. 2005

164. Xiao-Jun Qi et al. Evidence that Ser87 of BimEL is phosphorylated by Akt and regulates BimEL apoptotic function. 2006

165. Ming-Chuan Hsu et al. HER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factors to promote cell invasion. 2006

166. Polly J Phillips-Mason et al. The receptor protein-tyrosine phosphatase PTPmu interacts with IQGAP1. 2006

167. Soon-Young Choi et al. Activation of Bak and Bax through c-abl-protein kinase Cdelta-p38 MAPK signaling in response to ionizing radiation in human non-small cell lung cancer cells. 2006

168. Anna Moshnikova et al. The growth and tumor suppressor NORE1A is a cytoskeletal protein that suppresses growth by inhibition of the ERK pathway. 2006

169. Kyung Song et al. Novel permissive role of epidermal growth factor in transforming growth factor beta (TGF-beta) signaling and growth suppression. Mediation by stabilization of TGF-beta receptor type II. 2006

170. Seiji Ueno et al. Plasma membrane-associated sialidase is up-regulated in renal cell carcinoma and promotes interleukin-6-induced apoptosis suppression and cell motility. 2006

171. Alessandra Spaziani et al. Role of p38 MAPK and RNA-dependent protein kinase (PKR) in hepatitis C virus core-dependent nuclear delocalization of cyclin B1. 2006

172. GaÃ«l G McGill et al. c-Met expression is regulated by Mitf in the melanocyte lineage. 2006

173. Carlo Iavarone et al. Activation of the Erk8 mitogen-activated protein (MAP) kinase by RET/PTC3, a constitutively active form of the RET proto-oncogene. 2006

174. Jie Zhao et al. IRF-8/interferon (IFN) consensus sequence-binding protein is involved in Toll-like receptor (TLR) signaling and contributes to the cross-talk between TLR and IFN-gamma signaling pathways. 2006

175. Fred B Berry et al. Regulation of FOXC1 stability and transcriptional activity by an epidermal growth factor-activated mitogen-activated protein kinase signaling cascade. 2006

176. Sylvia M Major et al. AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. 2006

177. Tabetha M Bonacci et al. Differential targeting of Gbetagamma-subunit signaling with small molecules. 2006

178. Angela Iervolino et al. The receptor-type protein tyrosine phosphatase J antagonizes the biochemical and biological effects of RET-derived oncoproteins. 2006

home | browse | about